Company / Total Assets
Arcutis Biotherapeutics, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$433.0M
FY2025
5-year range
$341.4M / $449.3M
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
#152 of 214
Health Care
What the data says
At $433M, Arcutis Biotherapeutics, Inc.'s total assets ranks #152 of 214 in the Health Care sector. Improved from $341M to $433M over the past 2 years.
Based on SEC 10-K filings.
$433M in FY2025 with a 5-year CAGR of +7.7%.
Improved from $341M to $433M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
#152 of 214 in Health CareTop 71% of 214This company $433.0M Sector average $7.5B
▼
-94.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.7%, indicating consistent growth.
- In FY2025, total assets increased 24.1% year-over-year.
- Ranks #152 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $433.0M | +24.1% |
| FY2024 | $348.9M | +2.2% |
| FY2023 | $341.4M | -24.0% |
| FY2022 | $449.3M | +10.1% |
| FY2021 | $408.2M | +36.8% |
| FY2020 | $298.3M | +178.7% |
| FY2019 | $107.0M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026